Evommune to Host Webcast for EVO570 program
Evommune will discuss the in-licensing of EVO570 at a webcast scheduled for Thursday, highlighting progress in its immunology pipeline, a key area for biotechnology investors.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed